v3.26.1
Sage Acquisition - Narrative (Details)
$ / shares in Units, $ in Thousands
 3 Months Ended
Jul. 31, 2025
USD ($)
right
$ / shares
Mar. 31, 2026
USD ($)
$ / shares
Mar. 31, 2025
USD ($)
Dec. 31, 2025
$ / shares
Jun. 16, 2025
$ / shares
Business Combination [Line Items]          
Common stock, par value (in dollars per share) | $ / shares   $ 0.001   $ 0.001  
Amortization of intangible assets   $ 25,644 $ 19,786    
Sage Therapeutics, Inc.          
Business Combination [Line Items]          
Common stock, par value (in dollars per share) | $ / shares $ 0.0001        
Sage Therapeutics, Inc.          
Business Combination [Line Items]          
Business combination, price per share (in dollars per share) | $ / shares $ 8.50        
Aggregate consideration paid $ 561,000        
Contingents value rights | right 1        
Additional cash payments upon milestone achievements maximum $ 234,000 201,000      
Rights per share (in dollars per share) | $ / shares $ 3.50       $ 3.50
Contingent consideration, minimum   0      
Amortization of intangible assets   $ 300